First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

Based on the feedback received, this document may change. Learn about the consultation. Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC.

A urine drug test can quickly detect both illegal and prescription drugs in a person’s system. Doctors, sports officials, and many employers require these tests. Signs of drug use can remain in ...

(Photo Credit: Francis Sheehan/Science Source) The FDA has approved more than 30 antiretroviral drugs to treat HIV infection. They're often broken into nine classes because they work in different ...

As mentioned, we did conduct a food effect cohort study where we looked at giving 875 mg twice daily for mevrometostat with food, so a lower dose of the drug compared to what was tested in the ...

The president said Thursday proposed tariffs on Canada and Mexico would go into effect next week alongside the 10 percent tariff on China’s imports, citing the influx of drugs from all three ...

Drug developers are working on next-generation ... the androgen biosynthesis inhibitor abiraterone (Zytiga) and Arvinas’s first-generation and now-discontinued AR-degrader bavdegalutamide, ...

Approval of the drug for men with prostate cancer that has spread but has not yet become hormone resistant, would step up pressure on rival therapy Zytiga (abiraterone acetate) from Johnson ...

Drug discovery is extraordinarily difficult. “In 100 years or so of contemporary medicine, we’ve found treatments for only around 500 of the roughly 7,000 rare diseases,” says David Pardoe ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

the growing adoption of advanced monoclonal antibodies is the major factor driving the selling of Revlimid drugs. On the other hand, the Zytiga segment is expected to contribute a significant share in ...